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Abstract
Objective—The role of chemokines and their transporters are poorly described in rheumatoid
arthritis (RA). Evidence suggests that CXCL5 plays an important role as it is abundant in RA
tissue and its neutralization moderates joint damage in animal models of arthritis. The chemokine
transporter, Duffy Antigen Receptor for Chemokines (DARC), is also upregulated in early RA.
Here we investigate the role of CXCL5 and DARC in regulating neutrophil recruitment using an
in vitro model of the RA synovium.
Methods—To model the RA synovium, rheumatoid fibroblasts (RAF) were cocultured with
endothelial cells (EC) for 24h. Gene expression in cocultured cells was investigated using TaqMan
gene arrays. Roles of CXCL5 and DARC were determined by incorporating cocultures into a
flow-based adhesion assay, where their function was demonstrated by blocking neutrophil
recruitment with neutralizing reagents.
Results—EC-RAF coculture induced chemokine expression in both cell types. While CXC
chemokines were modestly upregulated in EC, CXCL1, CXCL5 and CXCL8 expression were
greatly increased in RAF. RAF also promoted the recruitment of flowing neutrophils to EC. Anti-
CXCL5 antibody abolished neutrophil recruitment by neutralizing CXCL5 expressed on EC, or
when used to immuno-deplete coculture conditioned medium. DARC was also induced on EC by
coculture and an anti-Fy6 antibody or siRNA targeting of DARC expression effectively abolished
neutrophil recruitment.
Conclusion—For the first time in a model of human disease, the function of DARC has been
demonstrated as essential for editing the chemokine signals presented by EC and for promoting
unwanted leukocyte recruitment.
The existence of a tissue specific address code for leukocyte recruitment during immune
surveillance and acute inflammation is well established with adhesion receptors and
chemokines being the primary coding elements (1, 2). However, the mechanisms of
leukocyte recruitment into the rheumatoid (RA) joint are ill-defined. In chronic
inflammation the address code presented on endothelial cells (EC) may reflect the abnormal
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inflammatory status of the tissue, with stromal cells producing an inappropriate profile of
chemokines for presentation to circulating leukocytes. CXCL5 (ENA-78) is secreted by
fibroblasts of the RA synovium and is elevated in synovial fluid and plasma of RA patients
compared to other arthritic diseases (3). Furthermore, CXCL5 is reported to be as important
as CXCL8 as a neutrophil chemoattractant in RA synovial fluid, with immuno-neutralization
abrogating over 40% of chemotaxis (3). In adjuvant-induced arthritis models in rats, CXCL5
is elevated in the serum and joint homogenates with levels correlating with disease
progression and clinical scores (4). Severity of disease was reduced by pre-treatment with
antibodies against CXCL5 (4). Together these observations demonstrate an important role
for CXCL5 in neutrophil recruitment in RA.
The Duffy Antigen Receptor for Chemokines (DARC) probably plays an important role in
editing the leukocyte recruitment code on EC. DARC is a promiscuous receptor which binds
some inflammatory chemokines with high affinity (5-7). However, DARC does not signal,
rather it facilitates the transcytosis of chemokines from the stromal to the apical side of EC
(8, 9) where glycosaminoglycans (GAGs) may present chemokines to leukocytes (7). DARC
is expressed on the synovial vasculature in RA (10), and is increased in the synovium during
early RA (11). These observations lead to the speculation that DARC might contribute to
inflammation by presenting chemokines generated by stromal cells within diseased
synovium (10, 11).
As both CXCL5 and DARC expression are increased in RA we speculate that presentation
of CXCL5 is regulated by DARC. However, such a role for DARC has never been
demonstrated in a human disease model. Here we used a coculture model of the RA
synovium (12) to reconstruct the chronically inflamed RA microenvironment in vitro, by
coculturing RA fibroblasts (RAF) or skin fibroblasts (SkF), as genetically matched control
stromal cells, with human EC. After a period of conditioning, fibroblasts and EC were
isolated and screened using microarray analysis. We show that recapitulating the RA
environment upregulated message for a number of CXC-chemokines in EC and RAF, an
effect absent in EC and SkF cocultures. Flow adhesion assays demonstrated that only
CXCL5 was functional on EC cocultured with RAF and recruited flowing neutrophils. EC
expression of DARC was induced by coculture with RAF and antibody blocking CXCL5
interactions with DARC or siRNA targeting DARC expression abolished neutrophil
recruitment. Thus for the first time, we demonstrate a role for DARC in editing the
leukocyte recruitment code in a chemokine specific manner and in a model of human
inflammatory disease.
Materials and Methods
EC and fibroblast cell culture
Methodology for the culture and coculture of RAF, SkF and EC has been described
previously (12, 13). Briefly, RAF and SkF were explanted from synovium or skin obtained
at total knee arthroplasty from consenting patients who fulfilled 1987 ARA criteria for RA
and represented genetically matched controls isolated from chronically inflamed and non-
inflamed tissue respectively (14, 15). Human umbilical vein EC were enzymatically isolated
and cultured to confluence. EC-fibroblast cocultures were grown on opposing sides of
porous culture plastic inserts (pore size; 0.4μm; BD Falcon) (12, 13). Cells were conditioned
for 24h prior to parallel plate flow-based leukocyte adhesion assay, or being isolated for
mRNA extraction or immunofluorimetry. Alternatively, conditioned medium from
cocultures was used to stimulate EC monolayers for 24h before being incorporated in the
flow assay
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Flow-based adhesion assay
The parallel plate assay was performed at 37°C on an upright fluorescent microscope
(Olympus BX61) at a wall shear stress of 0.1 Pa (12, 13). Human neutrophils were isolated
by density gradient centrifugation (Histopaque 1077 and 1119, Sigma), suspended in PBS
containing 0.1% BSA and fluorescently labeled with 1 μg/ml bisbenzimide. Neutrophils
were perfused at 106 cells/ml for 3 min, followed by cell-free buffer to remove non-adherent
cells. After a 2 min wash, video records were made of 10 fields along the centre of the
insert. Video was digitized using Image-Pro Plus (USA) and adherent cells expressed as
number /mm2/106 cells perfused.
TaqMan gene expression assays
EC and fibroblasts were isolated from either side of the culture membrane by trypsin
digestion. mRNA was extracted using an RNeasy Mini Kit 50 (Qiagen, Crawley, UK).
Duplicate analysis of the expression of 96 genes from cells isolated from two experiments
were assessed using TaqMan® low density arrays (Applied Biosystems [ABI], CA, USA).
Genes altered by a factor of 2-fold or more were analyzed in two further experiments by
quantitative real time-PCR (qRT-PCR). Primers and FAM-labeled probe sets for CXCL1
(forward: CGAAGT CATAGCCACACTCAAGAA; reverse:
GTTCAGCATCTTTTCGATGATTT TC; Probe: TGCCTCAATCCTGCATCCCCCAT)
and CXCL8 (forward: AAACCAC CGGAA GGAACCA; reverse:
TACCTTCACACAGAGCTGCAGAA; probe:TCCAA GCTGGC CGTGGCTCTCTT)
were designed using Primer Express® software v2.0 (ABI). Probes for CXCL5, DARC and
VIC-labeled beta-actin were Assay on Demand probes (ABI). In all samples, qRT-PCR
cycle threshold (Ct) values were normalized to ß-actin and expressed relative to the
calibrator samples of EC, SkF or RAF monocultures (RQ value).
Functional blocking antibodies and cytokine assays
In blocking experiments, purified anti-DARC (10 μg/ml; Fy6; New York Blood Centre) was
included in culture supernatant during coculture. For flow cytometry, EC were labeled for
15 min with anti-Fy6 or an isotype matched (IgG1) control antibody. FITC conjugated goat
anti-mouse IgG (DAKO Ltd, High Wycombe, UK) was the secondary antibody. Fluorescent
intensity was assessed on a Coulter EPICS XL flow cytometer (Beckman Coulter, High
Wycombe, UK). CXCL5 was blocked or depleted from the conditioned medium of EC and
RAF cocultures using anti-CXCL5 (10 μg/ml; Clone 33160.111; R&D systems) conjugated
Protein-G agarose beads (Upstate, Lake Placid, NY, USA). Anti-VCAM-1 (Clone 1.4C3;
DAKO) conjugated Protein-G agarose beads were used as the isotype control.
Beadlyte® Human Multi-cytokine Beadmaster™ kit (Upstate) was used to assay CXCL1
and CXCL8 in coculture supernatants. CXCL5 levels were measured using sandwich ELISA
(R&D Systems).
Transfection of EC with siRNA targeting DARC
EC were suspended by trypsin digestion and adjusted to 1 × 107 cells/ml in Nucleofector
solution (Amaxa AG, Cologne, Germany). To 100 μl of cell suspension (106 cells) 100nM
of either DARC siRNA (Invitrogen, Paisley, UK), or universal negative control siRNA (-
VE; Invitrogen), or phosphate buffered saline (to control for the effects of Nucleofector
Solution on EC viability and function) were added. Samples were transferred to Amaxa
certified cuvettes and electroporated using Amaxa apparatus on program A-34. Following
electroporation, 500 μl of pre-warmed EC culture medium was added to the cuvettes and
cells were transferred into 6-well plates to be incubated at 37° C with 5% CO2 for 24 hours.
Smith et al. Page 3
Arthritis Rheum. Author manuscript; available in PMC 2010 February 15.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Transfected EC from 2 donors were incorporated in to coculture with RAF from 2 different
donors and neutrophil adhesion assessed by flow assay as described above.
Statistical analysis
Data are mean ± SEM. Statistical comparisons were carried out using paired or unpaired t-
tests.
Results
An inflammatory environment is established in a coculture model of the RA synovium
TaqMan® low density arrays were used to screen EC and fibroblasts isolated from mono- or
co-culture (n=2). Table 1 provides a list of genes regulated in coculture by 2-fold or greater
compared to monocultured cells. In cells from EC and SkF cocultures 20 genes were
regulated (11 in EC and 9 in SkF, with 1 common to both). In the EC and RAF cocultures 14
genes were regulated (4 in EC and 11 in RAF, with 1 common to both cell types). Of these,
we selected 4 genes (CXCL1, CXCL5, CXCL8 and DARC) being of greatest relevance to
neutrophil recruitment, for further analysis in additional experiments. EC cocultured with
RAF but not SkF showed an upregulation of CXCL5 and DARC message by 4- and 7-fold
respectively compared to EC cultured alone (Figure 1a). Interestingly, in cocultured RAF,
CXCL1, CXCL5 and CXCL8 were highly elevated compared to fibroblasts cultured alone
(19-, 83- and 69-fold respectively; Figure 1b). DARC mRNA was not expressed in
fibroblasts under monoculture or coculture conditions (Figure 1b). Thus, genomic analysis
of RAF and EC indicated that the chemokine environment established upon coculture was
more complex than previously reported (12).
CXCL5 is selectively posted on cocultured EC and promotes neutrophil recruitment
Coculture of EC with RAF but not with SkF activated EC allowing recruitment of
neutrophils from flow (12). Neutrophil recruitment was β2 integrin and CXCR2 dependent
(12). Importantly, a function neutralizing antibody against CXCL5 reduced neutrophil
recruitment from 59 ± 8 /mm2/106 cells perfused to 10 ± 2 /mm2/106 cells perfused. Here,
adhesion assays conducted using EC monocultures activated with conditioned medium from
EC and RAF coculture for 24h, were also able to recruit neutrophils from flow (Figure 2A).
When CXCL5 was depleted from the conditioned medium, EC monocultures could not
support the recruitment of neutrophils (Figure 2A). Interestingly, cytokine analysis of
coculture supernatants showed that CXCL8 was present at high concentrations in both
monocultures (EC; 746 ±156 pg/ml) and cocultures (EC/SkF; pg/ml 892 ± 199 and EC-
RAF; 437 ± 112 pg/ml respectively; p=N.S.), although, CXCL1 and CXCL5 were below the
level of detection in the assays used. This strongly indicated that CXCL5 alone was posted
on the EC surface despite the presence of substantial concentrations of at least one other
CXC chemokine (i.e. CXCL8).
DARC is essential for posting CXCL5 on cocultured EC
The specific nature of CXCL5 driven neutrophil recruitment indicated that a selective
mechanism of chemokine transport and presentation might be operative. As mRNA for
DARC was significantly upregulated in cocultured EC we postulated that this receptor might
fulfill this role. DARC protein was found to be significantly upregulated on EC cocultured
with RAF (Figure 2B and C) and an antibody (anti-Fy6) that specifically blocks the
interaction of chemokines with DARC, abolished the adhesion of neutrophils to cocultured
EC (Figure 2D). Furthermore, when DARC expression in EC cocultured with RAF was
abrogated using siRNA, a similar reduction in the adhesion of neutrophils was seen (Figure
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2E). Taken together, these results strongly imply that the activity of CXCL5 was dependent
upon the function of DARC in cocultured EC.
Discussion
Here we modelled the RA synovium in vitro to identify mechanisms by which leukocytes
are recruited to this environment. Transcriptional changes in EC and RAF were found after a
period of residence in the recapitulated ‘synovium’. Importantly, we could utilise a
functional assay (a leukocyte adhesion assay) to demonstrate that transcriptional changes, in
particular of CXCL5 and DARC, were functionally relevant and were essential for the
recruitment of flowing neutrophils.
The chemokines used to recruit neutrophils to the RA synovium are not well-defined.
However, immunohistochemistry on diseased human tissue and inhibitor studies in animal
models of arthritis indicate an important role for CXCL5 (3, 4). We have previously
demonstrated a specific role for CXCL5 (rather than CXCL8 or CXCL1) in the recruitment
of neutrophils to our model of the RA synovium using function blocking antibodies (12).
Here we confirmed the importance of CXCL5 in neutrophil recruitment by demonstrating its
transcriptional upregulation during coculture and loss of function in our adhesion assay upon
immuno-depletion. The specificity of CXCL5 dependent neutrophil activation, even though
CXCL8 is abundantly secreted into coculture supernatants, suggests that selective
chemokine transport and presentation is occurring in this model of chronic inflammation.
Duffy Antigen Receptor for Chemokines (DARC) selectively binds most inflammatory but
not homeostatic chemokines (5). The chemokine binding properties of DARC have been
elucidated using radio-isotype competitive binding assays or the anti-Fya, Fy3 or Fy6
antibodies (16-18). Anti-Fy6 is a monoclonal antibody generated against Duffy antigen
receptor found on human red blood cells and can effectively block the interaction of
CXCL1, CXCL8, and CCL5 to DARC (17). Structural analysis of the receptor/ligand
interaction between DARC and its chemokine ligands has revealed that the location of the
FY6 epitope of DARC is closely involved in the chemokine binding properties of this
receptor (16). Here, we demonstrate that anti-Fy6 antibody blockade can also inhibit
neutrophil recruitment from flow onto EC/RAF cocultures probably through its ability to
displace CXCL5 binding to DARC. The functional effects of DARC in our coculture system
were confirmed using siRNA targeting EC DARC expression. Taken together these results
indicate that the regulation of DARC expression on EC by disease-transformed fibroblasts is
an important component in the recruitment of neutrophils to the inflamed RA synovium.
Although increased expression of DARC can be visualised by immuno-histochemistry in
inflamed and/or diseased human tissue, a definitive role for DARC in any human disease has
yet to be demonstrated. In vitro experiments, where immortalised EC have been transfected
with the human DARC gene, indicate that DARC expression increases the efficiency of
leukocyte recruitment, probably by transporting chemokines for presentation to circulating
leukocytes (8, 9). The use of more relevant study systems is hampered by the loss of DARC
on cultured EC and an inability to induce its expression with inflammatory cytokines (9).
This makes the current coculture model of the RA synovium of particular importance.
Firstly, it provides a disease specific leukocyte recruitment assay in which the contributions
of DARC and chemokines can be dissected. Secondly, it provides a model in which the
agent(s) that regulate the expression of DARC in EC can be investigated. To date we have
described a role for IL-6 in the cross-talk between RAF and EC (12). However, neutralising
this cytokine, or inhibiting its secretion by the addition of hydrocortisone to cocultures, does
effect DARC expression, at least at the level of mRNA production (12 and unpublished
observations). Thus, an unknown agent(s) is generated during RAF/EC coculture which
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induces DARC expression and is essential for neutrophil recruitment to our model
synovium. Through further characterisation of this model we may be able to identify new
therapeutic targets which moderate chronic inflammation in RA.
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Figure 1.
Effects of EC-RAF coculture on CXCL1, CXCL5, CXCL8 and DARC message in A) EC or
B) SkF and RAF from the RA joint. Data are expressed as mean ± SEM of 4 experiments
using different fibroblast explants and EC cultures. * = P<0.05; ** = P<0.01 for comparison
of cocultured cells against monocultured calibrator samples.
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Figure 2.
A) The effect of incubating monolayers of EC with coculture conditioned medium before or
after immuno-depletion using an anti-CXCL5 or control antibody; data are mean ± SEM of
4 experiments; * = P <0.05 for comparison of non depleted and antibody depleted
conditioned media; B) A representative histogram of the expression of DARC protein on EC
cultured alone or after coculture with RAF assessed by immunofluorimetry; C)
Quantification of EC surface expression of DARC, data are mean ± SEM of 4 experiments;
* = P <0.05 for comparison of EC monocultures and EC/RAF cocultures. D) The effect of
inhibiting the binding of chemokines to DARC using an anti-FY6 monoclonal antibody;
data are mean ± SEM of 4-12 experiments; * = P <0.05 for comparison of untreated and
antibody treated cells. E) The effect of siRNA targeting of DARC in EC in coculture with
RAF, data are mean ± SEM of 2 experiments.
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Table I
TaqMan® low density array analysis of EC and SKF or RAF cocultures
Gene arrays were performed on EC, SkF or RAF samples after monoculture or coculture for 24h (n=2). The
quantitative expression of target genes was determined relative to the housekeeping gene GAPDH and data
presented as the fold-increase or decrease of cocultured samples compared to the calibrator samples (EC, SkF
or RAF monocultures=1). Genes regulated by at least 2-fold were considered effected by coculture.
Target Gene EC with RAF RAF with EC EC with SkF SkF with EC
α7 Integrin 3.7 ± 1.1 NR 2.4 ± 0.8 NR
α10 Integrin NR 2.3 ± 0.9 NR 13.6 ± 5.6
β3 Integrin NR NR NR 2.8 ±1.1
β7 Integrin NR NR 2.9 ± 0.7 NR
CCL2 NR 4.3 ± 2.1 NR 6.8 ±1.9
CD44 NR NR NR 0.44 ± 0.1
COX2 NR 6.8 ± 4.4 NR NR
CXCL1 NR 6.4 ±1.6 0.4 ± 0.1 NR
CXCL5 3.8 ± 1.2 27.6 ± 13.8 2.1 ± 1.3 12.8 ±11.2
CXCL8 NR 36.4 ± 8.7 NR 30.7 ± 19.0
DARC 4.8 ± 2.0 NR 2.3 ± 1.0 NR
E-selectin NR 0.3 ± 0.1 NR NR
FLT-1 NR NR 2.5 ± 0.5 NR
11βHSDI NR 4.3 ± 2.2 NR 6.3 ± 1.5
ICAM-1 NR 3.1 ± 0.3 NR 12.5 ±6.2
ICAM-2 NR 2.2 ± 0.6 NR NR
OPG NR 0.4 ± 0.1 NR NR
P-selectin NR 0.3 ± 0.1 NR NR
RANK NR NR 3.8 ± 0.6 NR
SREBF-1 NR NR NR 2.0 ± 0.3
VCAM-1 0.4 ± 0.1 NR NR NR
VEGF NR 2.1 ± 0.3 2.4 ± 0.4 2.4 ± 0.4
NR= not regulated.
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